Targeted DNA RNA Sequencing Market
The targeted DNA and RNA sequencing market involves technologies for analyzing specific regions of the genome or transcriptome. Key customers include academic research institutions, hospitals, clinics, and pharmaceutical and biotech entities. The market's significant growth is driven by advancements in next-generation sequencing (NGS), the rising demand for personalized medicine, and the increasing prevalence of cancer and other genetic disorders.
CAGR
19.4%
Compound Annual Growth Rate
Current Value
$17.1B
Estimated 2026
Projected Value
$70.8B
By 2034